Steven A. Farber

From Wikipedia, the free encyclopedia

Steven Arthur Farber is an American scientist. He is a staff scientist at Carnegie Institution for Science.

Education[]

Steven Arthur Farber completed a bachelor of science in engineering with a major in electrical and biomedical engineering from Rutgers University in 1986. He earned a master of science in technology and policy in 1991 and a doctor of philosophy in neurology in 1993 at Massachusetts Institute of Technology.[1][2] His dissertation was titled Neuronal activity and membrane turnover in rat brain.[2] His thesis supervisor was Richard Wurtman. Farber was a Carnegie Fellow in Marnie Halpern's laboratory.[1]

Career[]

Farber was an assistant professor at Thomas Jefferson University. In 2004, he became a staff researcher at the Carnegie Institution for Science.[1] He works in the department of embryology. In 2018, he was awarded a 5-year $3.3 million NIH grant for researching novel pharmaceuticals and diseases associated with altered levels of lipoproteins.[3]

Together with Jamie Shuda he developed an outreach program named BioEYES which allowed students to gain hands-on biology experience by studying live zebrafish in the classroom.[4]

Honors and awards[]

References[]

  1. ^ a b c Science, Carnegie (2014-11-12). "Steven Farber". Carnegie Institution for Science. Retrieved 2018-12-26.
  2. ^ a b Farber, Steven Arthur (1993). Neuronal activity and membrane turnover in rat brain (Thesis thesis). Massachusetts Institute of Technology. hdl:1721.1/12673.
  3. ^ Science, Carnegie (2018-10-10). "Steven Farber Awarded $3.3-Million NIH Grant To Identify New Pharmaceuticals To Fight Cardiovascular Disease". Carnegie Institution for Science. Retrieved 2018-12-26.
  4. ^ a b "Genetics Society of America honors Steven Farber and Jamie Shuda with 2018 Elizabeth W. Jones Award for Excellence in Education". Genetics Society of America. Retrieved 5 February 2020.

External links[]

Retrieved from ""